Literature DB >> 31792033

Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia.

Christian Michel1, Elisabeth K.M. Mack1, Christopher-Nils Mais2, Lea V Fritz1, Ying Wang1, Lutz B. Jehn1, Sonja K. Hühn1, Clara Simon1, Sabrina Inselmann1, André Marquardt1, Jennifer Kremer1, Ellen Wollmer1, Kristina Sohlbach1, Andreas Neubauer1, Cornelia A. Brendel1, Claudia Haferlach3, Gert Bange2, Andreas Burchert4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31792033      PMCID： PMC7395268          DOI： 10.3324/haematol.2019.237818

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.

Authors:  K Farid Ahmad; Ari Melnick; Stuart Lax; Denis Bouchard; Jun Liu; Chih-Li Kiang; Sebastian Mayer; Shinichiro Takahashi; Jonathan D Licht; Gilbert G Privé
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

2.  Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib.

Authors:  Chan Y Cheah; Kate Burbury; Jane F Apperley; Francoise Huguet; Vincenzo Pitini; Martine Gardembas; David M Ross; Donna Forrest; Philippe Genet; Philippe Rousselot; Nigel Patton; Graeme Smith; Cynthia E Dunbar; Sawa Ito; Ricardo C T Aguiar; Olatoyosi Odenike; Alla Gimelfarb; Nicholas C P Cross; John F Seymour
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

3.  Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution.

Authors:  A Abe; N Emi; M Tanimoto; H Terasaki; T Marunouchi; H Saito
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

4.  Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing.

Authors:  Anna Stengel; Niroshan Nadarajah; Torsten Haferlach; Frank Dicker; Wolfgang Kern; Manja Meggendorfer; Claudia Haferlach
Journal:  Leukemia       Date:  2018-02-26       Impact factor: 11.528

5.  Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.

Authors:  X Li; H Peng; D C Schultz; J M Lopez-Guisa; F J Rauscher; R Marmorstein
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

6.  Structure of the POZ domain of human LRF, a master regulator of oncogenesis.

Authors:  Florian D Schubot; Joseph E Tropea; David S Waugh
Journal:  Biochem Biophys Res Commun       Date:  2006-10-09       Impact factor: 3.575

Review 7.  The BTB-ZF transcription factors.

Authors:  Owen M Siggs; Bruce Beutler
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 8.  Myeloid neoplasms with eosinophilia.

Authors:  Andreas Reiter; Jason Gotlib
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

9.  Crystal structure of the BTB domain from PLZF.

Authors:  K F Ahmad; C K Engel; G G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

10.  The Pu.1 target gene Zbtb11 regulates neutrophil development through its integrase-like HHCC zinc finger.

Authors:  Maria-Cristina Keightley; Duncan P Carradice; Judith E Layton; Luke Pase; Julien Y Bertrand; Johannes G Wittig; Aleksandar Dakic; Andrew P Badrock; Nicholas J Cole; David Traver; Stephen L Nutt; Julia McCoey; Ashley M Buckle; Joan K Heath; Graham J Lieschke
Journal:  Nat Commun       Date:  2017-04-06       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.